Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

NCT04280536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cohort A
DRUG: Cohort B

Sponsor

National University Hospital, Singapore